As chief executive, he steered online fashion portal Myntra into a $300 million-acquisition by the e-commerce company Flipkart. Today, the well-dressed and well-coiffed Mukesh Bansal moves away from the business of looking good to the business of feeling great—health platform Cure.fit.

Bansal is a man with an ambitious project that’s reaping quick benefits. Cure.fit raised $43 million in just one year, and now, it has a five-year plan of massive scale up with eyes firmly fixed on the urban middle class and corporate India.

Interestingly, Bansal’s greatest challenge is his antipode, yoga guru-turned-businessman Baba Ramdev. Separated by a decade in age, the two represent divergent outlooks to health, wellness and lifestyle. But they are not so far removed from each other in their end goals.

Through Cure.fit Bansal wants to capitalise on the current wave of what Ramdev’s Patanjali has come to symbolise.  “We want Cure.fit to stand for trust, sort of like Patanjali. Patanjali comes from yoga and spiritual angle, we are coming from a science and youth perspective,” he says. “Ultimately the goal is the same—to build a brand you can trust.”

Before you question the similarity, Bansal is quick to add that Patanjali has a ‘health’ positioning in the products it retails, yoga regimens it promotes, or Ayurveda clinics it runs in some cities. Though it’s another matter that there’s a difference between health positioning and actually delivering health to the customer.

A full stack health platform, with a mix of services and products sold through an app, and a full range branding with .fit, Bansal has the stacks sorted: Offline gyms for fitness in Cult.fit; meditation and yoga centres in Mind.fit; and hyperlocal health-food service in Eat.fit. And by early 2018, it even wants to get into primary healthcare, with Care.fit centres.

Each of these is a complex business. But Bansal is on a tear. Buying gyms, yoga centres and food delivery companies and rebranding them, even though he says “acquisition is not a big part of his strategy”. Cure.fit has acquired six companies in a year.

“We are building 90% of the business ourselves. We have targeted very small companies which can speed up our go-to-market by three to six months. We acquired Cult and Tribe for the teams running them,” he says. He’d like people to know that this time around he is not building a business for vanity metrics, rather a gross profitable business from the start.

Making money

Cure.fit does not monetise the services on its app as on date. It is treated as a customer acquisition channel to bring in sign-ups at its Cult.fit and Mind.fit outlets.

How does Bansal plan to do that given that most digital health companies, even globally, are chipping away on the fringes with no profitability or scale in sight?

AUTHOR

Payal Ganguly

Payal started writing news features six years ago and has written on startups, civic issues and education. Currently based out of Bengaluru, she has worked with The New Indian Express in Hyderabad and more recently, at The Economic Times, writing on e-commerce and logistics. A post-graduate in Molecular Biology and Biochemistry, she will be writing on e-commerce, science and technology at The Ken. She firmly believes that Bollywood classics have the power to heal and inspire.

View Full Profile

Available exclusively to subscribers of The Ken India

This story is a part of The Ken India edition. Subscribe. Questions?

MOST POPULAR

Annual Subscription

12-month access to 200+ stories, archive of 800+ stories from our India edition. Plus our premium newsletters, Beyond The First Order and The Nutgraf worth Rs. 99/month or $2/month each for free.

Rs. 2,750

Subscribe
 

Quarterly Subscription

3-month access to 60+ new stories with 3-months worth of archives from our India edition. Plus our premium newsletters, Beyond The First Order and The Nutgraf worth Rs. 99/month or $2/month each for free.

Rs. 1,750

Subscribe
 

Single Story

Instant access to this story for a year along with comment privileges.

Rs. 500

Subscribe
MOST POPULAR

Annual Subscription

12-month access to 150+ stories from Southeast Asia.

$ 120

Subscribe
 

Quarterly Subscription

3-month access to 35+ stories from Southeast Asia.

$ 50

Subscribe
 

Single Story

Instant access to this story for a year along with comment privileges.

$ 20

Subscribe

Questions?

What is The Ken?

The Ken is a subscription-only business journalism website and app that provides coverage across two editions - India and Southeast Asia.

What kind of stories do you write?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics.

We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

What do I get if I subscribe?

For subscribers of the India edition, we publish a new story every weekday, a premium daily newsletter, Beyond The First Order and a weekly newsletter - The Nutgraf.

For subscribers of the Southeast Asia edition, we publish a new story three days a week and a weekly newsletter, Strait Up.

The annual subscription will get you complete, exclusive access to our archive of previously published stories for your edition, along with access to our subscriber-only mobile apps, our premium comment sections, our newsletter archives and several other gifts and benefits.

Do I need to pay separately for your premium newsletters?

Nope. Paid, premium subscribers of The Ken get our newsletters delivered for free.

Does a subscription to the India edition grant me access to Southeast Asia stories? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

Do you offer an all-access joint subscription for both editions?

Not yet. If you’d like to access both editions, you’ll have to purchase two subscriptions separately - one for India and the other for Southeast Asia.

Do you offer any discounts?

No. We have a zero discounts policy.

Is there a free trial I can opt for?

We don’t offer any trials, but you can sign up for a free account which will give you access to the weekly free story, our archive of free stories and summaries of the paid stories. You can stay on the free account as long as you’d like.

Do you offer refunds?

We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Please write to us at [email protected] detailing the error or queries.